Results 91 to 100 of about 2,108 (191)
Early Real-World Outcomes of Switching to 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration in the United Kingdom [PDF]
(1) Aim: To evaluate early real-world outcomes of switching to aflibercept 8 mg in eyes with neovascular age-related macular degeneration (nAMD) in the United Kingdom. (2) Methods: This retrospective, observational study included 59 eyes from 50 patients
Azzopardi, Matthew +7 more
core +2 more sources
Investigating the feasibility of selective anti-VEGF delivery to the retina using a microinvasive approach [PDF]
Background: Retinal therapeutics has been revolutionized by anti-vascular endothelial growth factor (VEGF) therapies, whereby intravitreal injection is the accepted delivery method.
Arai, Mizuho +9 more
core +2 more sources
DiagnosticsTo assess changes in choriocapillaris (CC) vascular density surrounding macular neovascularization (MNV) in age-related macular degeneration (AMD) when transitioning from various anti-VEGF treatments to faricimab, using optical coherence tomography ...
Max Brinkmann +10 more
doaj +1 more source
Eye and VisionBackground This article describes a rare occurrence of bilateral retinal occlusive vasculitis secondary to intravitreal faricimab injection. Case presentation A 72-year-old female with age-related macular degeneration presented with bilateral retinal ...
Yong Min Lee +4 more
doaj +1 more source
Sterility of repackaged faricimab for intravitreal administration
Farmacia HospitalariaNew drugs such as faricimab have been developed to treat ophthalmic neovascular diseases. While these drugs increase treatment success, they also increase costs. Repackaging drugs strikes a balance between technical requirements and treatment flexibility.
Antonio, Raymundo +4 more
openaire +2 more sources
INTRAVITREAL FARICIMAB AS AN ADJUVANT IN THE MANAGEMENT OF TUBERCULAR UVEITIS
RETINAL Cases & Brief ReportsPurpose: The objective of this study was to report the use of intravitreal faricimab used as an adjunct in the management of intraocular tuberculosis in a patient with occlusive retinal vasculitis and choroiditis.
Yasmine Alcibahy +5 more
openaire +2 more sources
Beyond non-technical skills:training ophthalmologists to appraise and integrate emerging technologies [PDF]
As technology becomes increasingly complex and autonomous, ophthalmologists need to know the capabilities and limits of their tools.
Fioratou, Evie, Whitelaw, Thomas A.
core +1 more source
Choroidal thickness after anti-vascular endothelial growth factor in typical neovascular age-related macular degeneration – A systematic review and meta-analysis [PDF]
Age-related macular degeneration (AMD) is one of the leading causes of blindness in the world and anti-vascular endothelial growth factor (VEGF) injections have been the standard of care for the wet/neovascular variant since 2004.
Hoven, Erlend +3 more
core +1 more source
Improving Clinic Capacity with Faricimab
EMJ InnovationsClinic capacity constraints are an ever-increasing problem in ophthalmology. Multiple case studies demonstrate that faricimab frees up clinic capacity with extended treatment intervals in both treatment-naïve and treatment-experienced patients. In this symposium, three case studies from the UK and Spain demonstrated how fewer appointments per patient ...
David Wong +3 more
openaire +1 more source